Literature DB >> 19781609

Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery.

Ye Wang1, Xiang Li, Yan Zhou, Pengyu Huang, Yuhong Xu.   

Abstract

Echogenic bubble formulations have wide applications in both disease diagnosis and therapy. In the current study, nanobubbles were prepared and the contrast agent function was evaluated in order to study the nanosized bubble's property for ultrasonic imaging. Coumarin-6 as a model drug was loaded into nanobubbles to investigate the drug delivery potential to cells. The results showed that the nanobubbles composed of 1% of Tween 80, and 3 mg/ml of lipid worked well as an ultrasonic contrast agent by presenting a contrast effect in the liver region in vivo. The drug-loaded nanobubbles could enhance drug delivery to cells significantly, and the process was analyzed by sigmoidally fitting the pharmacokinetic curve. It can be concluded that the nanobubble formulation is a promising approach for both ultrasound imaging and drug delivery enhancing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19781609     DOI: 10.1016/j.ijpharm.2009.09.027

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  34 in total

Review 1.  Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.

Authors:  Alicia Fernandez-Fernandez; Romila Manchanda; Anthony J McGoron
Journal:  Appl Biochem Biotechnol       Date:  2011-09-27       Impact factor: 2.926

2.  Contrast-enhanced ultrasound: The evolving applications.

Authors:  Hui-Xiong Xu
Journal:  World J Radiol       Date:  2009-12-31

3.  Effects of the microbubble shell physicochemical properties on ultrasound-mediated drug delivery to the brain.

Authors:  Shih-Ying Wu; Cherry C Chen; Yao-Sheng Tung; Oluyemi O Olumolade; Elisa E Konofagou
Journal:  J Control Release       Date:  2015-06-09       Impact factor: 9.776

Review 4.  Personalized nanomedicine advancements for stem cell tracking.

Authors:  Miroslaw Janowski; Jeff W M Bulte; Piotr Walczak
Journal:  Adv Drug Deliv Rev       Date:  2012-07-20       Impact factor: 15.470

Review 5.  Ultrasound imaging beyond the vasculature with new generation contrast agents.

Authors:  Reshani H Perera; Christopher Hernandez; Haoyan Zhou; Pavan Kota; Alan Burke; Agata A Exner
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-01-08

6.  Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation.

Authors:  T Noguchi; K Ebina; M Hirao; T Morimoto; K Koizumi; K Kitaguchi; H Matsuoka; T Iwahashi; H Yoshikawa
Journal:  Osteoporos Int       Date:  2016-11-28       Impact factor: 4.507

7.  Breast Cancer Brain Metastasis Response to Radiation After Microbubble Oxygen Delivery in a Murine Model.

Authors:  Lauren J Delaney; Lorela Ciraku; Brian E Oeffinger; Corinne E Wessner; Ji-Bin Liu; Jingzhi Li; Kibo Nam; Flemming Forsberg; Dennis B Leeper; Patrick O'Kane; Margaret A Wheatley; Mauricio J Reginato; John R Eisenbrey
Journal:  J Ultrasound Med       Date:  2019-05-23       Impact factor: 2.153

8.  Novel dual-mode nanobubbles as potential targeted contrast agents for female tumors exploration.

Authors:  Hengli Yang; Tian Zhou; Wenbin Cai; Xiaomin Yi; Xi Liu; Yixiao Wang; Li Zhang; Yunyou Duan
Journal:  Tumour Biol       Date:  2016-08-19

9.  A magnetic nanoparticle stabilized gas containing emulsion for multimodal imaging and triggered drug release.

Authors:  Wei Guo; Diancheng Li; Jia-an Zhu; Xiaohui Wei; Weiwei Men; Dazhi Yin; Mingxia Fan; Yuhong Xu
Journal:  Pharm Res       Date:  2014-04-10       Impact factor: 4.200

10.  Development of an ultrasound sensitive oxygen carrier for oxygen delivery to hypoxic tissue.

Authors:  John R Eisenbrey; Lorenzo Albala; Michael R Kramer; Nick Daroshefski; David Brown; Ji-Bin Liu; Maria Stanczak; Patrick O'Kane; Flemming Forsberg; Margaret A Wheatley
Journal:  Int J Pharm       Date:  2014-11-18       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.